Mika Lehto

2.8k total citations · 2 hit papers
103 papers, 1.9k citations indexed

About

Mika Lehto is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Internal Medicine. According to data from OpenAlex, Mika Lehto has authored 103 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Cardiology and Cardiovascular Medicine, 21 papers in Epidemiology and 17 papers in Internal Medicine. Recurrent topics in Mika Lehto's work include Atrial Fibrillation Management and Outcomes (80 papers), Cardiac Arrhythmias and Treatments (45 papers) and Cardiac electrophysiology and arrhythmias (20 papers). Mika Lehto is often cited by papers focused on Atrial Fibrillation Management and Outcomes (80 papers), Cardiac Arrhythmias and Treatments (45 papers) and Cardiac electrophysiology and arrhythmias (20 papers). Mika Lehto collaborates with scholars based in Finland, Sweden and Denmark. Mika Lehto's co-authors include Kristian Wachtell, Björn Hornestam, Richard B. Devereux, Markku S. Nieminen, Eva Gerdts, Lars Lindholm, Hans Ibsen, Michael Hecht Olsen, Sverre E. Kjeldsen and Stevo Julius and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Mika Lehto

90 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

2005 570 citations Mika Lehto et al. profile →
Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort

2024 41 citations Konsta Teppo, Gregory Y.H. Lip et al. The Lancet Regional Health - Europe profile →

Peers

Countries citing papers authored by Mika Lehto

Since Specialization

Citations

This map shows the geographic impact of Mika Lehto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika Lehto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika Lehto more than expected).

Fields of papers citing papers by Mika Lehto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika Lehto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika Lehto. The network helps show where Mika Lehto may publish in the future.

Co-authorship network of co-authors of Mika Lehto

This figure shows the co-authorship network connecting the top 25 collaborators of Mika Lehto. A scholar is included among the top collaborators of Mika Lehto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika Lehto. Mika Lehto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Heart Failure and Stroke Risk in Atrial Fibrillation: Temporal Trends From a Nationwide Cohort Study 2025 ·Journal of the American Heart Association ·(unknown), Ville L. Langén, Jussi Jaakkola, Juhani Airaksinen, Olli Halminen, Jukka Putaala, (unknown), Jari Haukka, Juha Hartikainen, Miika Linna, Mika Lehto, Konsta Teppo	0
2	Reduced dose direct oral anticoagulants and time-in-therapeutic-range defined warfarin in new-onset atrial fibrillation: a report from the nationwide FinACAF study 2025 ·European Heart Journal Open ·(unknown), Mika Lehto, Olli Halminen, (unknown), Mikko Niemi, Konsta Teppo, (unknown), Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Aapo L. Aro, Juha Hartikainen, Gregory Y.H. Lip, Juhani Airaksinen	0
3	Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort breakdown → 2024 ·The Lancet Regional Health - Europe ·Konsta Teppo, Gregory Y.H. Lip, Juhani Airaksinen, Olli Halminen, Jari Haukka, Jukka Putaala, (unknown), Miika Linna, Juha Hartikainen, Mika Lehto	41
4	Sex- and age-specific differences in the use of antiarrhythmic therapies among atrial fibrillation patients: a nationwide cohort study 2024 ·EP Europace ·Birgitta Salmela, Jussi Jaakkola, (unknown), J Inkovaara, Aapo L. Aro, Konsta Teppo, (unknown), Olli Halminen, Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Juha Hartikainen, Juhani Airaksinen, Mika Lehto	3
5	Temporal trends in hypertension-related ischaemic stroke risk in atrial fibrillation from 2007 to 2018: a nationwide cohort study 2024 ·European Journal of Preventive Cardiology ·Konsta Teppo, Ville L. Langén, Juhani Airaksinen, (unknown), Jussi Jaakkola, Olli Halminen, Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Juha Hartikainen, Mika Lehto	3
6	Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study 2024 ·Annals of Medicine ·Mika Lehto, (unknown), Olli Halminen, Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Janne Kinnunen, (unknown), Konsta Teppo, (unknown), (unknown), (unknown), Mikko Niemi, Aapo L. Aro, Juha Hartikainen, Juhani Airaksinen, (unknown)	3
7	Temporal trends in mortality and causes of death in patients with incident atrial fibrillation: a nationwide register study from 2010 to 2018 2024 ·BMJ Open ·(unknown), Birgitta Salmela, Aapo L. Aro, Olli Halminen, Konsta Teppo, Jari Haukka, Jukka Putaala, (unknown), Pirjo Mustonen, Juha Hartikainen, Juhani Airaksinen, Mika Lehto	4
8	Temporal relation of disease onsets in patients with acute myocardial infarction and atrial fibrillation - results from a nationwide registry study 2023 ·EP Europace ·(unknown), Tuomas Kiviniemi, Olli Halminen, (unknown), Jari Haukka, Pirjo Mustonen, Jukka Putaala, Miika Linna, Juha Hartikainen, Juhani Airaksinen, Mika Lehto	0
9	Aortic Stenosis and Outcomes in Patients With Atrial Fibrillation: A Nationwide Cohort Study 2023 ·Journal of the American Heart Association ·Konsta Teppo, Juhani Airaksinen, Fausto Biancari, Jussi Jaakkola, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, (unknown), Juha Hartikainen, Aapo L. Aro, Mika Lehto	3
10	Temporal trends of gender disparities in oral anticoagulant use in patients with atrial fibrillation 2023 ·European Journal of Clinical Investigation ·Konsta Teppo, Juhani Airaksinen, Jussi Jaakkola, Olli Halminen, Birgitta Salmela, (unknown), (unknown), Jari Haukka, Jukka Putaala, Miika Linna, Aapo L. Aro, Pirjo Mustonen, Juha Hartikainen, Mika Lehto	15
11	Ischemic Stroke Temporally Associated With New-Onset Atrial Fibrillation: A Population-Based Registry-Linkage Study 2023 ·Stroke ·Jukka Putaala, Konsta Teppo, Olli Halminen, Jari Haukka, (unknown), Jussi Jaakkola, (unknown), Miika Linna, Pirjo Mustonen, Janne Kinnunen, Tuomas Kiviniemi, Aapo L. Aro, Juha Hartikainen, Juhani Airaksinen, Mika Lehto, (unknown)	8
12	Abstract 12046: Patient Characteristics and Use of Oral Anticoagulation Therapy in New-Onset Atrial Fibrillation: Results From a Nationwide Registry Study in Finland 2022 ·Circulation ·(unknown), (unknown), Olli Halminen, Jari Haukka, Mikko Niemi, Jaana Kuoppala, Pirjo Mustonen, Jukka Putaala, Miika Linna, Juha Hartikainen, Juhani Airaksinen, Mika Lehto	1
13	Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland 2022 ·European Heart Journal - Quality of Care and Clinical Outcomes ·Konsta Teppo, Juhani Airaksinen, Jussi Jaakkola, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Juha Hartikainen, Aapo L. Aro, Mika Lehto	21
14	Income and outcomes of patients with incident atrial fibrillation 2022 ·Journal of Epidemiology & Community Health ·Fausto Biancari, Konsta Teppo, Jussi Jaakkola, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Juha Hartikainen, Aapo L. Aro, Juhani Airaksinen, Mika Lehto	12
15	Mental health conditions and use of rhythm control therapies in patients with atrial fibrillation: a nationwide cohort study 2022 ·BMJ Open ·Konsta Teppo, Jussi Jaakkola, Fausto Biancari, Olli Halminen, Jukka Putaala, Pirjo Mustonen, Jari Haukka, Miika Linna, Janne Kinnunen, (unknown), (unknown), (unknown), Mikko Niemi, Juha Hartikainen, Juhani Airaksinen, Mika Lehto	3
16	The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics 2022 ·European Journal of Epidemiology ·Mika Lehto, Olli Halminen, Pirjo Mustonen, Jukka Putaala, Miika Linna, Janne Kinnunen, (unknown), (unknown), Juha Hartikainen, Jari Haukka, Juhani Airaksinen	36
17	Prolonged ECG with a novel recorder utilizing electrode belt and mobile device in patients with recent embolic stroke of undetermined source: A pilot study 2020 ·Annals of Noninvasive Electrocardiology ·(unknown), (unknown), Jukka Putaala, Gerli Sibolt, Anne M Kerola, Sami Pakarinen, Mika Lehto, Tuomo Nieminen	9
18	Continuous 4‐week ECG monitoring with adhesive electrodes reveals AF in patients with recent embolic stroke of undetermined source 2019 ·Annals of Noninvasive Electrocardiology ·(unknown), Jukka Putaala, Anne M Kerola, Gerli Sibolt, (unknown), Sami Pakarinen, Mika Lehto, Tuomo Nieminen	16
19	Use of antihypertensive medication after ischemic stroke in young adults and its association with long-term outcome 2018 ·Annals of Medicine ·(unknown), Karoliina Aarnio, Nicolas Martinez‐Majander, (unknown), Juha Sinisalo, Mika Lehto, Markku Kaste, Turgut Tatlisumak, Frank‐Erik de Leeuw, Jukka Putaala	12
20	Optimal timing for cardioversion in patients with atrial fibrillation 2018 ·Clinical Cardiology ·Tapio Hellman, Tuomas Kiviniemi, Ilpo Nuotio, Fausto Biancari, Tuija Vasankari, Juha Hartikainen, Mika Lehto, Juhani Airaksinen, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact